WC
GWPH

Weil Company’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

Weil Company’s Portfolio GWPH Stock Details GWPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-113
Closed -$13K – 379
2019
Q3 		$13K Buy
+113
New +$17.2K 0.01% 270

Other funds holding GWPH

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
MGIM
M&G Investment Management London, United Kingdom $28.2B AUM 25.87% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Weil Company's GWPH Position: Q4 2019 in Review

Weil Company sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q4 2019, closing a stake of 113 shares — an estimated $13K sold.

Weil Company first reported a position in GWPH in Q3 2019 and held it in 1 quarter. The position peaked at $13K in Q3 2019. 318 funds tracked by Wall St. Rank hold GWPH as of Q4 2019.

  • Weil Company reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q4 2019 after selling out during the quarter.
  • Weil Company sold 113 GW Pharmaceuticals Plc American Depositary Shares shares in Q4 2019, an estimated $13K.
  • Weil Company first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q3 2019 and held it in 1 quarter.
  • Weil Company's GW Pharmaceuticals Plc American Depositary Shares position peaked at $13K in Q3 2019.
  • 318 funds tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q4 2019.

Based on Weil Company's 13F filing for Q4 2019, filed 13 Feb 2020.